Connection
David Wyles to Oligopeptides
This is a "connection" page, showing publications David Wyles has written about Oligopeptides.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.451 |
|
|
|
-
Wyles DL. Beyond telaprevir and boceprevir: resistance and new agents for hepatitis C virus infection. Top Antivir Med. 2012 Oct-Nov; 20(4):139-45.
Score: 0.355
-
Cachay ER, Wyles DL, Torriani FJ, Ballard C, Colwell B, Lin JC, Hill L, Mathews WC. High incidence of serious adverse events in HIV-infected patients treated with a telaprevir-based hepatitis C virus treatment regimen. AIDS. 2013 Nov 28; 27(18):2893-7.
Score: 0.096